Cancer
-
As the second leading cause of death globally, treating – or even better, curing – cancer is understandably high on the list of researchers’ priorities. Here are New Atlas’ top cancer stories for the year 2023.
-
Being diagnosed with potentially fatal metastatic breast cancer inspired one man to gather a team of diverse professionals to create an AI-based tool to help oncologists provide an individualized treatment care plan to patients with metastatic cancer.
-
Researchers have found that inexperienced doctors performing AI-assisted colonoscopies significantly improved their detection of polyps. Using AI in this way could lower the chances of missing these potential precursors to colorectal cancer.
-
A clinical trial has demonstrated that psilocybin-assisted therapy is effective at treating depression in patients with cancer. In a first, the drug was given to small groups of patients simultaneously, before they underwent one-on-one and group therapy.
-
In what has already been tagged as a “game-changer” for cancer treatment, the potent once-a-day tablet known as divarasib has continued to impress at Phase 1b trial stage, outperforming not just current therapies but its previous trial results.
-
Beans don't have the best rep when it comes to our guts. But a new study has shown how a daily dose of navy beans can easily restore gut health in colorectal cancer survivors, revealing their broad benefit in helping protect against chronic diseases.
-
A study has found that a fatty acid found in meat and dairy may boost the cancer-killing abilities of the immune system’s T cells. Also found to enhance the effectiveness of immunotherapy, the nutrient could be used to complement cancer treatments.
-
A new study has identified, for the first time, how the mutated protein p53, present in half of all human cancers, drives tumor growth. The discovery will not only facilitate a rethink of the way cancer is treated but may lead to new therapeutics.
-
A study has uncovered how the commonly used local anesthetic drug lidocaine exerts an anti-cancer effect in head and neck cancers. Given its low cost and ready availability, the drug could easily be incorporated into treatment.
-
A Phase 2 clinical trial of immunotherapy drug tarlatamab, produced promising results in patients with small cell lung cancer, a particularly aggressive form of cancer, for whom previous treatments haven't worked.
-
A study has found a link between higher consumption of ultra-processed foods and the risk of developing some cancers. However, they found that obesity, often caused by eating too much of these foods, was not a large contributing factor.
-
You don't have to be a chemistry whiz to know that making a drug for $3 is a damn sight better than its current price tag of $3,200. The scientists behind this never-before-seen method centered around copper and oxygen say it's an industry game-changer.
Load More